Skip to main navigation Skip to search Skip to main content

Autophagy in malignant transformation and cancer progression

  • Lorenzo Galluzzi
  • , Federico Pietrocola
  • , José Manuel Bravo-San Pedro
  • , Ravi K. Amaravadi
  • , Eric H. Baehrecke
  • , Francesco Cecconi
  • , Patrice Codogno
  • , Jayanta Debnath
  • , David A. Gewirtz
  • , Vassiliki Karantza
  • , Alec Kimmelman
  • , Sharad Kumar
  • , Beth Levine
  • , Maria Chiara Maiuri
  • , Seamus J. Martin
  • , Josef Penninger
  • , Mauro Piacentini
  • , David C. Rubinsztein
  • , Hans Uwe Simon
  • , Anne Simonsen
  • Andrew M. Thorburn, Guillermo Velasco, Kevin M. Ryan, Guido Kroemer
  • Centre de Recherche des Cordeliers
  • Université Paris-Sud
  • Université Paris Cité
  • University of Pennsylvania
  • University of Massachusetts Medical School
  • Danish Cancer Society
  • University of Rome Tor Vergata
  • Institut Necker-Enfants Malades (INEM)
  • CNRS
  • University of California at San Francisco
  • Virginia Commonwealth University
  • Merck & Co.
  • Dana-Farber Cancer Institute
  • University of South Australia
  • University of Texas Southwestern Medical Center
  • Trinity College Dublin
  • Institute of Molecular Biotechnology
  • IRCCS Istituto per le Malattie Infettive Lazzaro Spallanzani - Roma
  • University of Cambridge
  • University of Bern
  • University of Oslo
  • University of Colorado Anschutz Medical Campus
  • Complutense University
  • Hospital Clínico San Carlos de Madrid
  • Beatson Institute for Cancer Research
  • Assistance publique – Hôpitaux de Paris

Research output: Contribution to journal › Article › peer-review

1106 Scopus citations

Abstract

Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells, such a homeostatic activity constitutes a robust barrier against malignant transformation. Accordingly, many oncoproteins inhibit, and several oncosuppressor proteins promote, autophagy. Moreover, autophagy is required for optimal anticancer immunosurveillance. In neoplastic cells, however, autophagic responses constitute a means to cope with intracellular and environmental stress, thus favoring tumor progression. This implies that at least in some cases, oncogenesis proceeds along with a temporary inhibition of autophagy or a gain of molecular functions that antagonize its oncosuppressive activity. Here, we discuss the differential impact of autophagy on distinct phases of tumorigenesis and the implications of this concept for the use of autophagy modulators in cancer therapy. Autophagy has been described to have tumor-suppressive as well as tumor-promoting functions. This review discusses how stage and context alters the role for autophagy in cancer, and argues for further research prior to targeting autophagy in cancer therapy.

Original languageEnglish
Pages (from-to)856-880
Number of pages25
JournalEMBO Journal
Volume34
Issue number7
DOIs
StatePublished - Apr 1 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adaptive stress responses
  • Beclin 1
  • KRAS
  • inflammation
  • mitophagy

Fingerprint

Dive into the research topics of 'Autophagy in malignant transformation and cancer progression'. Together they form a unique fingerprint.

Cite this